Announcements Trials
Browse Landscape

Status

Terminated 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Stress Disorders, Post-Traumatic 1Parkinson Disease 1Pain, Intractable 1Neoplasms 1Muscle Spasticity 1Multiple Sclerosis 1Inflammatory Bowel Diseases 1Huntington Disease 1Glaucoma 1Epilepsy 1Dyskinesias 1Chronic Disease 1Autism Spectrum Disorder 1Anemia, Sickle Cell 1Acquired Immunodeficiency Syndrome 1

Interventions

Docetaxel 56Prednisone 36enzalutamide 25Leuprolide 24Magnetic Resonance Spectroscopy 19Abiraterone Acetate 19bicalutamide 17Radiotherapy 15Goserelin 15abiraterone 12acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 11olaparib 9Androgen Antagonists 9gallium 68 PSMA-11 8cabazitaxel 8Radiotherapy, Intensity-Modulated 8Metformin 8Ketoconazole 8Gonadotropin-Releasing Hormone 8Cyclophosphamide 8apalutamide 7Doxorubicin 7luprolide acetate gel depot 6cabozantinib 6Radiosurgery 6Estramustine 6Dexamethasone 6Calcitriol 6Biopsy 6pembrolizumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Prostatic Neoplasms × Registries × Clear all
NCT03553732 2022-08-04

An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital

University of California, San Francisco

Terminated
48 enrolled
Genitourinary

Chronic Disease, Prostatic Neoplasms

NCT02454595 2017-09-05

Registry to Measure the Impact of Adding Genomic Testing

Myriad Genetic Laboratories, Inc.

Terminated
116 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡